Literature DB >> 23219666

Region-specific expression of vesicular glutamate and GABA transporters under various ischaemic conditions in mouse forebrain and retina.

D Michalski1, W Härtig, K Krügel, R H Edwards, M Böddener, L Böhme, T Pannicke, A Reichenbach, A Grosche.   

Abstract

There is accumulating evidence that glutamate and GABA release are key mechanisms of ischaemic events in the CNS. However, data on the expression of involved transporters for these mediators are inconsistent, potentially impeding further neuroprotective approaches. Here, we applied immunofluorescence labelling to characterise the expression pattern of vesicular glutamate (VGLUT) and GABA transporters (VGAT) after acute focal cerebral ischaemia and in two models of retinal ischaemia. Mice were subjected to filament-based focal cerebral ischaemia predominantly involving the middle cerebral artery territory, also leading to retinal ischaemia due to central retinal artery occlusion (CRAO). Alternatively, retinal ischaemia was induced by a transient increase of the intraocular pressure (HIOP). One day after ischaemia onset, diminished immunolabelling of neuronal nuclei and microtubule-associated protein 2-positive structures were found in the ipsilateral neocortex, subcortex and the retina, indicating neuronal degeneration. VGLUT1 expression did not change significantly in ischaemic tissues whereas VGLUT2 was down-regulated in specific areas of the brain. VGLUT3 expression was only slightly down-regulated in the ischaemia-affected neocortex, and was found to form clusters on fibrils of unknown origin in the ischaemic lateral hypothalamus. In contrast, retinae subjected to CRAO or HIOP displayed a rapid loss of VGLUT3-immunoreactivity. The expression of VGAT appears resistant to ischaemia as there was no significant alteration in all the regions analysed. In summary, these data indicate a region- and subtype-specific change of VGLUT expression in the ischaemia-affected CNS, whose consideration might help to generate specific neuroprotective strategies.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219666     DOI: 10.1016/j.neuroscience.2012.11.046

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

Review 1.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

2.  Differential maturation of vesicular glutamate and GABA transporter expression in the mouse auditory forebrain during the first weeks of hearing.

Authors:  Troy A Hackett; Amanda R Clause; Toru Takahata; Nicholas J Hackett; Daniel B Polley
Journal:  Brain Struct Funct       Date:  2015-07-10       Impact factor: 3.270

3.  Control of retinal blood flow levels by selected combinations of cervical arterial ligations in rat.

Authors:  Norman P Blair; Sophie Leahy; Mahnaz Shahidi
Journal:  Exp Eye Res       Date:  2020-06-02       Impact factor: 3.467

4.  Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia.

Authors:  Martin Krueger; Ingo Bechmann; Kerstin Immig; Andreas Reichenbach; Wolfgang Härtig; Dominik Michalski
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

5.  Stroke-induced blood-brain barrier breakdown along the vascular tree - No preferential affection of arteries in different animal models and in humans.

Authors:  Martin Krueger; Wolfgang Härtig; Clara Frydrychowicz; Wolf C Mueller; Andreas Reichenbach; Ingo Bechmann; Dominik Michalski
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.

Authors:  Ran Antes; Raaya Ezra-Elia; Dov Weinberger; Arie Solomon; Ron Ofri; Daniel M Michaelson
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction.

Authors:  Susanne Wiemann; Aisha Yousf; Stephanie C Joachim; Carolin Peters; Ana M Mueller-Buehl; Natalie Wagner; Jacqueline Reinhard
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

8.  The Cytoskeletal Elements MAP2 and NF-L Show Substantial Alterations in Different Stroke Models While Elevated Serum Levels Highlight Especially MAP2 as a Sensitive Biomarker in Stroke Patients.

Authors:  Bianca Mages; Thomas Fuhs; Susanne Aleithe; Alexandra Blietz; Constance Hobusch; Wolfgang Härtig; Stefan Schob; Martin Krueger; Dominik Michalski
Journal:  Mol Neurobiol       Date:  2021-05-01       Impact factor: 5.590

9.  Central Mechanisms Mediating Thrombospondin-4-induced Pain States.

Authors:  John Park; Yanhui Peter Yu; Chun-Yi Zhou; Kang-Wu Li; Dongqing Wang; Eric Chang; Doo-Sik Kim; Benjamin Vo; Xia Zhang; Nian Gong; Kelli Sharp; Oswald Steward; Iuliia Vitko; Edward Perez-Reyes; Cagla Eroglu; Ben Barres; Frank Zaucke; Guoping Feng; Z David Luo
Journal:  J Biol Chem       Date:  2016-04-19       Impact factor: 5.486

10.  Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina.

Authors:  T Pannicke; I Frommherz; B Biedermann; L Wagner; K Sauer; E Ulbricht; W Härtig; U Krügel; U Ueberham; T Arendt; P Illes; A Bringmann; A Reichenbach; A Grosche
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.